| 25 May 2026 |
EPO |
6.1 |
10mg |
9.9mg |
-1.1% |
98.87% |
Lab C |
| 25 May 2026 |
Lipo-C 120mg |
8.6 |
200mg/ml |
223.6mg/ml |
+11.8% |
95.56% |
Lab G |
| 24 May 2026 |
Adipotide |
5.5 |
15mg |
17.2mg |
+14.4% |
95.94% |
Lab C |
| 24 May 2026 |
Aromasin (Exemestane) |
8.8 |
20mg |
17.1mg |
-14.5% |
98.00% |
Lab A |
| 24 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.2 |
30mg |
30.9mg |
+3.1% |
98.88% |
Lab C |
| 24 May 2026 |
Romosozumab |
7.3 |
20mg |
18.4mg |
-7.9% |
96.32% |
Lab G |
| 24 May 2026 |
Tadalafil (Cialis) |
4.2 |
10mg |
9.3mg |
-7.3% |
99.98% |
Lab G |
| 23 May 2026 |
HCG |
7.7 |
20mg |
24.9mg |
+24.7% |
97.49% |
Lab C |
| 23 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.8 |
1g |
0.9g |
-5.2% |
96.77% |
Lab E |
| 23 May 2026 |
Glutathione |
5.8 |
10mg |
11.8mg |
+17.8% |
96.90% |
Lab B |
| 21 May 2026 |
Deca (Nandrolone Decanoate) |
4.3 |
250mg/ml |
255.2mg/ml |
+2.1% |
98.93% |
Lab C |
| 21 May 2026 |
SNAP-8 |
6.5 |
2mg |
2.0mg |
+1.8% |
95.26% |
Lab F |
| 21 May 2026 |
Oxytocin Acetate |
7.6 |
50mg |
57.8mg |
+15.7% |
96.56% |
Lab F |
| 20 May 2026 |
Dutasteride |
8.8 |
100mg |
118.5mg |
+18.5% |
95.86% |
Lab C |
| 19 May 2026 |
Masteron P (Drostanolone P) |
4.3 |
100mg/ml |
102.3mg/ml |
+2.3% |
97.96% |
Lab D |
| 19 May 2026 |
Vitamin B12 10mg/ml |
5.8 |
100mg/ml |
93.1mg/ml |
-6.9% |
96.75% |
Lab B |
| 17 May 2026 |
TrenMix 200 |
6.0 |
250mg/ml |
302.7mg/ml |
+21.1% |
96.39% |
Lab E |
| 17 May 2026 |
Trestolone Acetate (MENT) Raw |
8.5 |
10g |
11.7g |
+17.0% |
98.55% |
Lab F |
| 29 Jan 2026 |
ACE-031 |
8.1 |
30mg |
34.9mg |
+16.3% |
98.21% |
Lab B |
| 29 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
4.7 |
10mg |
8.9mg |
-11.5% |
99.32% |
Lab G |
| 26 Jan 2026 |
AA Water |
5.3 |
30mg |
35.4mg |
+18.0% |
95.98% |
Lab F |
| 26 Jan 2026 |
Boldenone Cypionate |
6.1 |
250mg/ml |
297.0mg/ml |
+18.8% |
95.47% |
Lab A |
| 26 Jan 2026 |
Botulinum toxin |
6.3 |
2mg |
2.2mg |
+11.9% |
97.08% |
Lab A |
| 26 Jan 2026 |
IGF-1 LR3 |
8.6 |
5mg |
5.0mg |
+0.9% |
95.96% |
Lab A |
| 26 Jan 2026 |
NA Selank Amidate |
7.5 |
30mg |
30.6mg |
+2.0% |
98.63% |
Lab C |
| 19 Jan 2026 |
Clomid |
5.6 |
50mg |
54.5mg |
+9.0% |
96.09% |
Lab C |
| 9 Jan 2026 |
Winstrol Oil |
7.5 |
300mg/ml |
371.0mg/ml |
+23.7% |
95.37% |
Lab E |
| 7 Jan 2026 |
Tirzepatide |
6.0 |
20mg |
22.4mg |
+12.0% |
99.90% |
Lab G |
| 6 Jan 2026 |
APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 |
5.8 |
10g |
8.9g |
-10.7% |
97.10% |
Lab B |
| 10 Dec 2025 |
Retatrutide |
5.8 |
10mg |
10.9mg |
+9.0% |
99.50% |
Lab G |
| 5 Dec 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.5 |
10mg |
11.6mg |
+15.6% |
96.59% |
Lab F |
| 23 Nov 2025 |
AICAR |
4.0 |
15mg |
13.5mg |
-10.2% |
99.61% |
Lab G |
| 17 Nov 2025 |
Cerebrolysin |
7.1 |
10mg |
11.1mg |
+11.0% |
98.62% |
Lab F |
| 5 Nov 2025 |
Epithalon |
5.4 |
20mg |
21.1mg |
+5.5% |
97.84% |
Lab E |
| 4 Nov 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.2 |
10mg |
9.6mg |
-4.5% |
99.73% |
Lab D |
| 17 Oct 2025 |
4-Anilinopiperidine CAS 99918-43-1 |
4.5 |
500g |
569.8g |
+14.0% |
97.22% |
Lab B |
| 17 Oct 2025 |
Testagen |
7.3 |
50mg |
59.9mg |
+19.8% |
98.06% |
Lab C |
| 14 Oct 2025 |
Retatrutide |
4.2 |
10mg |
12.2mg |
+22.0% |
99.60% |
Lab G |
| 9 Oct 2025 |
Retatrutide |
7.3 |
30mg |
30.3mg |
+1.0% |
99.60% |
Lab E |
| 6 Oct 2025 |
Retatrutide |
4.0 |
10mg |
12.4mg |
+24.0% |
99.50% |
Lab G |
| 3 Oct 2025 |
Tirzepatide |
7.7 |
10mg |
10.1mg |
+1.0% |
99.79% |
Lab E |
| 30 Sep 2025 |
Retatrutide |
8.0 |
30mg |
28.6mg |
-4.7% |
99.92% |
Lab E |